Alan Dunton - Sep 19, 2024 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Julio C. Esquivel, as Attorney-in-Fact for Alan Dunton
Stock symbol
OGEN
Transactions as of
Sep 19, 2024
Transactions value $
$0
Form type
4
Date filed
9/20/2024, 09:15 PM
Previous filing
Jul 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Non-Employee Director Option (Right to Buy) Award $0 +65K $0.00 65K Sep 19, 2024 Common Stock 65K $0.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.